Gastroenterology & Hepatology

Hepatitis B and Hepatitis C

We invite researchers to submit abstracts for the "Hepatitis B and Hepatitis C" track at GASTROENTEROLOGY-2024. This track will focus on advancing our understanding and management of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, two major global health challenges.

Abstract submissions should highlight novel insights into viral pathogenesis, diagnostic innovations, treatment strategies, and outcomes in diverse patient populations. Topics of interest include antiviral therapies, immune modulation approaches, viral resistance mechanisms, and the impact of comorbidities on disease progression.

What to Expect:

Attendees can anticipate dynamic discussions featuring leading experts, comprehensive updates on recent clinical trials, and the latest guidelines for managing HBV and HCV infections. The track will address emerging therapeutic targets, vaccine development efforts, and public health initiatives aimed at reducing the global burden of viral hepatitis.

Join us at GASTROENTEROLOGY-2024 to contribute to the advancement of hepatitis research and to collaborate on strategies for optimizing patient care in this critical area of gastroenterology.